Case studies

Securing a €30M Lifeline for a Visionary AI Pioneer

This case study highlights our ability to navigate challenging capital markets by crafting a compelling narrative and tapping our exclusive network of investors to secure critical growth funding for a truly innovative company.

The situation

A prominent European philanthropic foundation and its founding partners approached us with a monumental vision: to create a €20B+ investment vehicle dedicated to fostering global peace and "integral human development." Their mission was to leverage cutting-edge innovations in AI and Neuroscience to address deep societal needs.

The challenge was immense. They had a powerful philosophical framework but needed a trusted partner to translate this abstract vision into a concrete, institutional-grade investment strategy, a viable financial structure, and a pipeline of world-class deals to anchor the initial capital raise.

Our action

Recognizing that this was not a standard venture deal, our approach was two-fold: craft a world-class narrative and execute a highly targeted capital raise.

Refined the Investment Narrative: We worked tirelessly alongside the founders to craft a compelling story. We moved beyond the technology to articulate the profound impact their platform would have on human well-being and cognition, unlocking a tremendous and untapped market at the intersection of AI, health, and personalized therapy.

Executed a Targeted Capital Raise: Instead of a broad outreach, we immediately tapped our proprietary network of specialized family offices and private investors. We targeted partners who we knew were seeking visionary, high-impact opportunities and had the sophistication to understand the deep science behind the venture.

The situation

We were approached by the founders of a revolutionary startup creating AI-generated soundscapes. Their technology, backed by extensive neuroscience research and collaborations with high-profile European institutions, had the potential to transform human wellness.

Despite a successful Series A round two years prior, the company was facing significant cash constraints. The global slowdown in the financial markets had made their existing investors hesitant, and they needed to secure a €30 million investment from a new, core institution that understood and shared their profound vision for the future of holistic health.

The result

Our targeted, narrative-driven approach allowed us to succeed where a traditional process would have failed.
In just three months, we secured a €30 million investment commitment and a binding term sheet from a strategic family office. More importantly, we found more than just a capital provider; we secured a true partner who shares the founders' vision and has committed to leading any follow-on capital raises. With closing documentation in process, the company is now on a clear path to being fully capitalized and poised for global growth.

Hauptstr. 28, 15806 Zossen, Germany

contact@avkadvisors.global

© 2025 AVK Advisors GmbH. All rights reserved.

Hauptstr. 28, 15806 Zossen, Germany

contact@avkadvisors.global

© 2025 AVK Advisors GmbH. All rights reserved.

Hauptstr. 28, 15806 Zossen, Germany

contact@avkadvisors.global

© 2025 AVK Advisors GmbH. All rights reserved.